Re: Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy: K. E. M. van Kessel, W. Beukers, I. Lurkin, A. Ziel-van der Made, K. A. van der Keur, J. L. Boormans, L. Dyrskjøt, M. Márquez, T. F. Ørntoft, F. X. Real, U. Segersten, N. Malats, P.-U. Malmström, W. Van Criekinge and E. C. Zwarthoff J Urol 2017;197:590-595.

Autor: Wang Z; Departments of Urology and Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China., Bi SS; Departments of Urology and Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China., Wang L; Departments of Urology and Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China. Electronic address: doctorwanglong@163.com.

Publikováno v: The Journal of urology [J Urol] 2017 Jun; Vol. 197 (6), pp. 1573. Date of Electronic Publication: 2017 Mar 02.

A Novel Gene Expression Scoring System Predicts Recurrence in Non‐Muscle‐Invasive Bladder Cancer Patients.

Autor: Kayama, Emina¹ (AUTHOR), Uemura, Motohide^1,2 (AUTHOR) muemura@fmu.ac.jp, Onagi, Akifumi¹ (AUTHOR), Meguro, Satoru¹ (AUTHOR), Ogawa, Soichiro¹ (AUTHOR), Yaginuma, Kei¹ (AUTHOR), Matsuoka, Kanako¹ (AUTHOR), Hoshi, Seiji¹ (AUTHOR), Koguchi, Tomoyuki¹ (AUTHOR), Hata, Junya¹ (AUTHOR), Sato, Yuichi¹ (AUTHOR), Akaihata, Hidenori¹ (AUTHOR), Honma, Reiko³ (AUTHOR), Watanabe, Shinya⁴ (AUTHOR), Kojima, Yoshiyuki¹ (AUTHOR)

Publikováno v: Cancer Medicine. Nov2024, Vol. 13 Issue 22, p1-9. 9p.

Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group

Autor: M, Porta, S, Costafreda, N, Malats, L, Guarner, M, Soler, J M, Gubern, E, García-Olivares, M, Andreu, A, Salas, J M, Corominas, J, Alguacil, A, Carrato, J, Rifà, F X, Real

Publikováno v: European journal of epidemiology. 16(6)

The aim was to analyse the magnitude, direction and predictors of change in the main hospital discharge diagnosis (HDD) after a clinical expert review, among patients included in a multicentre molecular epidemiologic study of biliopancreatic diseases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::21f3b01f3c831869e70be5aefcd1f749
https://pubmed.ncbi.nlm.nih.gov/11049097

Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group

Autor: M, Porta, N, Malats, M, Jariod, J O, Grimalt, J, Rifà, A, Carrato, L, Guarner, A, Salas, M, Santiago-Silva, J M, Corominas, M, Andreu, F X, Real

Publikováno v: Lancet (London, England). 354(9196)

Organochlorine compounds such as 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p,p'-DDT), 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (p,p'-DDE), and some polychlorinated biphenyls (PCBs) are carcinogenic to animals and possibly also to human bei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa0e3067f18e73af7ad67b0e530cb6dd
https://pubmed.ncbi.nlm.nih.gov/10609819

Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer

Autor: M, Soler, M, Porta, N, Malats, L, Guarner, S, Costafreda, J M, Gubern, E, García-Olivares, M, Andreu, F X, Real

Publikováno v: Journal of clinical epidemiology. 51(12)

Epidemiologic studies on exocrine pancreatic cancer show a large heterogeneity in diagnostic criteria applied to define "caseness." Reanalyses conducted after review of diagnostic information have yielded substantially different results than those ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59b98528732535b64bcae6a2cbc3c3b1
https://pubmed.ncbi.nlm.nih.gov/10086813